AR002997A1 - 4-Cloro-2-Ä1(r)-ciclopropiletnil-1-hidroxi-1-trifluormetilÜ-metil-anilinas n-protegida y procedimientos para su síntesis asimétrica. - Google Patents

4-Cloro-2-Ä1(r)-ciclopropiletnil-1-hidroxi-1-trifluormetilÜ-metil-anilinas n-protegida y procedimientos para su síntesis asimétrica.

Info

Publication number
AR002997A1
AR002997A1 AR10267196A AR10267196A AR002997A1 AR 002997 A1 AR002997 A1 AR 002997A1 AR 10267196 A AR10267196 A AR 10267196A AR 10267196 A AR10267196 A AR 10267196A AR 002997 A1 AR002997 A1 AR 002997A1
Authority
AR
Argentina
Prior art keywords
trifluoromethylu
cyclopropylethyl
anilines
chloro
hydroxy
Prior art date
Application number
AR10267196A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR002997A1 publication Critical patent/AR002997A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/70Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AR10267196A 1995-05-25 1996-05-22 4-Cloro-2-Ä1(r)-ciclopropiletnil-1-hidroxi-1-trifluormetilÜ-metil-anilinas n-protegida y procedimientos para su síntesis asimétrica. AR002997A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/450,330 US5633405A (en) 1995-05-25 1995-05-25 Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Publications (1)

Publication Number Publication Date
AR002997A1 true AR002997A1 (es) 1998-05-27

Family

ID=23787667

Family Applications (1)

Application Number Title Priority Date Filing Date
AR10267196A AR002997A1 (es) 1995-05-25 1996-05-22 4-Cloro-2-Ä1(r)-ciclopropiletnil-1-hidroxi-1-trifluormetilÜ-metil-anilinas n-protegida y procedimientos para su síntesis asimétrica.

Country Status (26)

Country Link
US (2) US5633405A (es)
EP (1) EP0828703B1 (es)
JP (1) JP2839717B2 (es)
KR (1) KR100399511B1 (es)
CN (1) CN1119319C (es)
AR (1) AR002997A1 (es)
AT (1) ATE196463T1 (es)
AU (1) AU709273B2 (es)
BR (1) BR9608839A (es)
CA (1) CA2220389C (es)
CZ (1) CZ292848B6 (es)
DE (1) DE69610422T2 (es)
DK (1) DK0828703T3 (es)
EA (1) EA000107B1 (es)
ES (1) ES2151666T3 (es)
GR (1) GR3034897T3 (es)
HR (1) HRP960233B1 (es)
HU (1) HU223565B1 (es)
MX (1) MX199501B (es)
NZ (1) NZ308824A (es)
PT (1) PT828703E (es)
SK (1) SK282412B6 (es)
TW (1) TW402581B (es)
UA (1) UA56137C2 (es)
WO (1) WO1996037457A1 (es)
YU (1) YU48940B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004535A1 (en) * 1996-07-26 1998-02-05 Du Pont Pharmaceuticals Company A practical synthesis of benzoxazinones useful as hiv reverse transcriptase inhibitors
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US5932726A (en) * 1996-12-16 1999-08-03 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones
AU5521498A (en) * 1996-12-16 1998-07-15 Du Pont Pharmaceuticals Company An improved synthesis of cyclopropylacetylene
CA2276074A1 (en) * 1997-01-10 1998-07-16 Merck & Co., Inc. Efficient synthesis of a chiral mediator
KR100573192B1 (ko) * 1997-02-05 2006-04-24 머크 앤드 캄파니 인코포레이티드 역-용매를 사용한 역전사효소 억제제의 결정화 방법 및 당해 역전사효소 억제제의 결정형
AU760075B2 (en) * 1997-02-05 2003-05-08 Merck Sharp & Dohme Corp. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
US5965729A (en) * 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
TW480253B (en) * 1997-02-12 2002-03-21 Merck & Co Inc Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one
US5922864A (en) * 1997-02-12 1999-07-13 Merck & Co., Inc. Efficient synthesis of a 1,4-dihydro2H-3,1-benzoxazin-2-one
WO1998045278A1 (en) * 1997-04-07 1998-10-15 Du Pont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones via new intermediates
AR011731A1 (es) * 1997-05-16 2000-08-30 Merck & Co Inc Un proceso de reaccion de adicion enantioselectiva eficiente utilizando un reactivo de organozinc.
EP1001919A4 (en) * 1997-08-06 2000-10-11 Merck & Co Inc EFFICIENT SYNTHESIS OF CYCLOPROPYLACETYLEN
US6072094A (en) * 1997-08-06 2000-06-06 Merck & Co., Inc. Efficient synthesis of cyclopropylacetylene
WO1999048848A1 (en) * 1998-03-24 1999-09-30 Great Lakes Chemical Corporation Method to reduce the amount of phosphorus oxyhalides and dihalogenated pentenes in 1,1-dihalo-1-cyclopropylethanes
PE20000559A1 (es) * 1998-05-27 2000-07-05 Merck & Co Inc Formulacion de tabletas comprimidas de efavirenz
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
EP1332757B1 (en) * 1998-05-27 2012-06-13 Merck Sharp & Dohme Corp. Efavirenz compressed tablet formulation
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
HRP990182A2 (en) * 1998-06-11 2000-02-29 Du Pont Pharm Co Crystalline efavirenz
US6235957B1 (en) 1998-06-29 2001-05-22 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
WO2000018706A1 (en) 1998-10-01 2000-04-06 Du Pont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
US6288297B1 (en) 1998-10-01 2001-09-11 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
GB2355724A (en) 1999-10-28 2001-05-02 Merck & Co Inc Synthesis of cyclopropylacetylene from propiolic acid (2-propynoic acid)
GB2355988A (en) 1999-10-28 2001-05-09 Merck & Co Inc Synthesis of cyclopropylacetylene in a one-pot process using a diazo-keto-phos phonate
WO2004087628A1 (fr) * 2003-04-04 2004-10-14 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Ligand amino-alcool et son utilisation dans la preparation d'alcools tertiaires propargyliques et d'amines tertiaires par le biais d'une reaction d'addition eniantioselective
CN1331601C (zh) * 2003-05-16 2007-08-15 中国科学院上海有机化学研究所 手性氨基醇配体应用于端炔对含氟烷基芳基酮的不对称加成的方法
US7271252B2 (en) 2003-04-22 2007-09-18 Roche Diagnostics Operations, Inc. Reagents for detecting efavirenz
US7420043B2 (en) * 2003-12-10 2008-09-02 Roche Diagnostics Operations, Inc. Reagents for detecting efavirenz
ZA200806473B (en) * 2008-01-31 2009-04-29 Aptuit Laurus Pvt Ltd An efficient process to induce enantioselectivity in procarbonyl compounds
US9073817B2 (en) 2008-01-31 2015-07-07 Laurus Labs Private Limited Efficient process to induce enantioselectivity in procarbonyl compounds
EP2313379B1 (en) * 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
EP2417097A2 (en) 2009-04-09 2012-02-15 Lonza Ltd. Autocatalytic process for the synthesis of chiral propargylic alcohols
EP2417096B1 (en) 2009-04-09 2013-01-16 Lonza Ltd. Process for the synthesis of a propargylic alcohol
EP2448917A2 (de) 2009-07-03 2012-05-09 Archimica GmbH Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447247A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of chiral propargylic alcohols
EP2471783A1 (en) 2010-12-23 2012-07-04 Esteve Química, S.A. Novel polymorphic form of efavirenz
CN102617370B (zh) * 2012-03-05 2014-06-04 浙江江北药业有限公司 (S)-5-氯-α-(环丙乙炔基)-2-(((4-甲氧基苯基)甲基)氨基)-α-(三氟甲基)苯甲醇的制备方法
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
US9676735B2 (en) 2015-08-27 2017-06-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Process for the preparation of efavirenz and devices suitable therefore
DE202015104551U1 (de) 2015-08-27 2015-12-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
JP7071036B2 (ja) 2019-02-15 2022-05-18 福建永晶科技股▲ふん▼有限公司 Friedel-Crafts反応の新しい新方法及び当該方法に用いられる触媒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55145625A (en) * 1979-05-01 1980-11-13 Mitsubishi Chem Ind Ltd Preparation of alkynyl alcohol
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase

Also Published As

Publication number Publication date
JPH10506642A (ja) 1998-06-30
HU223565B1 (hu) 2004-09-28
WO1996037457A1 (en) 1996-11-28
CZ292848B6 (cs) 2003-12-17
JP2839717B2 (ja) 1998-12-16
ATE196463T1 (de) 2000-10-15
SK282412B6 (sk) 2002-01-07
ES2151666T3 (es) 2001-01-01
GR3034897T3 (en) 2001-02-28
CN1185146A (zh) 1998-06-17
US5633405A (en) 1997-05-27
MX9709064A (es) 1998-03-31
CN1119319C (zh) 2003-08-27
NZ308824A (en) 1998-11-25
US5698741A (en) 1997-12-16
EP0828703A1 (en) 1998-03-18
CZ370997A3 (cs) 1998-04-15
CA2220389A1 (en) 1996-11-28
BR9608839A (pt) 1999-06-08
AU5866796A (en) 1996-12-11
PT828703E (pt) 2001-01-31
TW402581B (en) 2000-08-21
YU31496A (sh) 1998-11-05
DE69610422T2 (de) 2001-04-19
HUP9802566A3 (en) 2001-01-29
EP0828703B1 (en) 2000-09-20
CA2220389C (en) 2005-12-06
YU48940B (sh) 2002-12-10
DE69610422D1 (de) 2000-10-26
HRP960233B1 (en) 2001-08-31
MX199501B (es) 2000-11-10
UA56137C2 (uk) 2003-05-15
DK0828703T3 (da) 2000-11-20
HRP960233A2 (en) 1997-08-31
EA000107B1 (ru) 1998-08-27
SK156997A3 (en) 1998-09-09
AU709273B2 (en) 1999-08-26
EA199700426A1 (ru) 1998-06-25
HUP9802566A2 (hu) 1999-06-28
KR100399511B1 (ko) 2003-12-31
KR19990021899A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
AR002997A1 (es) 4-Cloro-2-Ä1(r)-ciclopropiletnil-1-hidroxi-1-trifluormetilÜ-metil-anilinas n-protegida y procedimientos para su síntesis asimétrica.
DE69632547D1 (de) Trokaranordnung
BR9703875A (pt) Distribuidor para meios
DE69512624T2 (de) Copolycarbonat
BR9509436A (pt) Inibidores de síntese de apoliproteina-B
NL194659B (nl) Uithaalorgaan.
KR960030737U (ko) 앨범
DE59505759D1 (de) Binderrücken
DE29511982U1 (de) Pflaster
DE29623174U1 (de) Medienverteiler
NO983371D0 (no) Kontrastmedier
DE29512971U1 (de) Werbeträger
KR970000761U (ko) 앨범 내지
DE29508173U1 (de) Kühlvorrichtung
DE29502279U1 (de) Absperrhahn
DE29500480U1 (de) Trokar
KR970016581U (ko) 앨범용 대지
ES1031388Y (es) Soporte para cubiertas de invernadero y similares.
ES1032781Y (es) Banda abdominal para termolipolisis.
DE69508118T2 (de) Laparoskopische einführvorrichtung
KR970023715U (ko) 자연형 호안블럭
ES1030219Y (es) Accesorio-soporte para botellas y similares.
KR970000777U (ko)
KR960033792U (ko)
DE29512433U1 (de) Werbeträger